Le Lézard
Classified in: Health
Subjects: PER, LGB, DEI

Fenway Health hires Jordina Shanks as Chief Executive Officer


The Fenway Health Board of Directors is thrilled to announce today that it has hired Jordina Shanks as Fenway Health's next CEO. Shanks has been serving as Fenway's Interim CEO since March.

BOSTON, June 13, 2024 /PRNewswire-PRWeb/ -- The Fenway Health Board of Directors is thrilled to announce today that it has hired Jordina Shanks as Fenway Health's next CEO. Shanks has been serving as Fenway's Interim CEO since March. Prior to that she served three years as Fenway Health's Chief Operating Officer. Shanks was selected from a diverse pool of more than 90 applicants, with the support of executive search firm Spencer Stuart who conducted a nationwide search for Fenway's next CEO.

"I am deeply honored to step into the role of CEO to serve Fenway Health. I am inspired by the compassionate clinicians and staff [and] I am proud of the high-quality affirming care that welcomes patients as their authentic selves."

"Since joining Fenway Health in 2021, Jordina has expertly led efforts that have improved access to care for our patients and clients. She has also led and implemented strategies over the last 24 months that have dramatically improved the financial performance of the organization," said Fenway Health Board Chair Scott Walker. "As Fenway Health continues to adapt to a post-pandemic healthcare environment that impacts health care organizations in Boston, in Massachusetts, and across the country, we have every confidence in Jordina's ability to lead Fenway Health in both innovative and sustainable new directions in the years to come."

Shanks is a healthcare expert with over 30 years' experience in a variety of settings in the Greater Boston area. She has a proven record of improving patient safety, quality, provider, patient, and staff satisfaction, as well as increasing profitability. Since joining Fenway Health in 2021, she has employed a data-driven approach to assess and respond to issues and concerns, encouraged innovative, staff-driven solutions, and held racial and health equity at the center of all business decisions. Prior to joining Fenway Health, Shanks served as Chief Operating Officer at Mattapan Community Health Center and at Planned Parenthood League of Massachusetts.

"I am deeply honored to step into the role of CEO to serve Fenway Health. I am inspired by the compassionate clinicians and staff who show up every day for our patients and each other, despite navigating the challenges that are affecting many health care organizations. I am proud of the high-quality affirming care that welcomes patients as their authentic selves," said Shanks. "Fenway Health plays a critical role as a leading provider of care, education, research, and advocacy for LGBTQIA+ people and those affected by HIV and our impact is felt across the country. Looking ahead, we will continue centering racial and health equity and engage in deep partnership with community organizations to meet the needs of those who continue to face staggering barriers to care. Fenway is here for every member of the LGBTQIA+ community and people living with HIV."

Founded in 1971, Fenway Health advocates for and delivers innovative, equitable, accessible health care, supportive services, and transformative research and education. We center LGBTQIA+ people, BIPOC individuals, and other underserved communities to enable our local, national, and global neighbors to flourish. The Fenway Institute at Fenway Health is an interdisciplinary center for research, training, education and policy development focusing on national and international health issues.

Media Contact

Christopher A Viveiros, Fenway Health, 6177217494, [email protected], www.fenwayhealth.org

SOURCE Fenway Health


These press releases may also interest you

at 08:48
With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories...

at 08:45
111, Inc. ("111" or the "Company") , a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced  the appointment of...

at 08:40
The "Gene Therapy Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Gene Therapy Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene...

at 08:39
In the third wave of the landmark longitudinal study on gratitude conducted by Eastern Washington University (EWU) and Gracianna Winery, gratitude remains the highest-rated positive emotion among Americans, showing significant recovery from the early...

at 08:38
Legacy, North America's #1 digital fertility clinic for men, has secured $7.5M in financing to power its mission to make male fertility services more accessible, including through the fulfillment of two recently signed contracts to serve over nine...

at 08:35
Ora, the leading global ophthalmic contract research organization (CRO), is excited to announce that it has been recapitalized by The Vistria Group, a middle-market private investment firm that seeks to deliver both financial returns and societal...



News published on and distributed by: